Adenosine Receptor

Adenosine Receptor

Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiological actions of adenosine. Four AR subtypes have so far been cloned and found in various tissues. When exposed to agonists, these receptors exhibit unique localization, signal transduction pathways, and modes of regulation. The capacity of some Adenosine receptors to act as sensors of cellular oxidative stress, which is transmitted by transcription factors like NF-B to control the expression of ARs, is one of their key characteristics. We'll look at the role of adenosine receptors in the control of healthy and unhealthy processes, including sleep, the growth of cancer, and the prevention of hearing loss.

Adenosine Receptor related products

Structure Cat No. Product Name CAS No. Product Description
V17958 Namodenoson (2 Cl-IB-MECA; CF102) 163042-96-4 Namodenoson (2-Cl-IB-MECA; CF102; CF-102) is a novel, potent, orally bioavailable, and highly selective adenosine A3 receptor (A3AR) agonist with potential anticancer activity.
V2200 NBMPR 38048-32-7 NBMPR(NBTI) is a nucleoside analog that competitively inhibits the equilibrative nucleoside transporter 1 (Kd = 0.1-1.0 nM, IC50s = 4.6 and 3.6 nM in rat and human, respectively).
V11965 Nicergoline 27848-84-6 Nicergoline tartrate is a naturally occuring ergot derivative and a vasoactive drug with α-adrenergic blocking activity, producing vasodilatation.
V13165 Norepinephrine (Levarterenol; L-Noradrenaline) 51-41-2 Norepinephrine (Levarterenol; L-Noradrenaline) is a potent and β1-selective adrenergic receptor agonist with EC50 of 5.37 μM.
V75273 NPC 200 (1,3-Dipropyl-8-phenylxanthine) 85872-53-3 NPC 200 is a potent Adenosine A1 Receptor selective antagonist.
V13861 Olodaterol 868049-49-4 Olodaterol (formerly known as BI-1744; BI1744; STRIVERDI RESPIMAT)is a ultra-long acting beta-adrenoceptor agonist approved in 2014 for use as an inhalation for treating patients with chronic obstructive pulmonary disease (COPD) It was developed and manufactured by Boehringer-Ingelheim.
V27563 Piclidenoson (CF-101) 152918-18-8 Piclidenoson, formerly known as CF101, is a specific agonist to the A3 adenosine receptor, which inhibits the development of colon carcinoma growth in cell cultures and xenograft murine models.
V3944 Preladenant (MK-3814; SCH420814) 377727-87-2 Preladenant (formerly known as MK-3814; SCH-420814) is a novel potent, selective and competitive antagonist of adenosine A2A receptor with potential immunomodulatory effects and may be used for the treatment for Parkinson's disease.
V3125 Proxyphylline 603-00-9 Proxyphylline is a derivative of methylxanthine that is clinically used as a cardiac stimulant, a vasodilator and a bronchodilator.
V75261 PSB 0777 ammonium 2122196-16-9 PSB 0777 ammonium is a potent and specific adenosine A2A receptor agonist/activator with Kis of 44.4 nM and 360 nM for rat and human A2A receptors respectively.
V76587 PSB 0777 ammonium hydrate PSB 0777 ammonium hydrate is a potent and specific adenosine A2A receptor agonist/activator with Kis of 44.4 nM and 360 nM for rat and human A2A receptors respectively.
V75266 PSB-10 hydrochloride 591771-91-4 PSB-10 HCl is a potent and specific human adenosine A3 receptor (A3AR) antagonist (inhibitor) with a Ki of 0.44 nM.
V75260 PSB-1901 2332835-02-4 PSB-1901 is a potent A2B adenosine receptor (A2BAR) antagonist (inhibitor) with Kis of 0.0835 nM and 0.131 nM for human and mouse A2BAR, respectively.
V75279 PSB11 hydrochloride 453591-58-7 PSB11 HCl is an antagonist (inhibitor) with inverse agonistic activity of human A3 adenosine receptor and has high affinity (Ki=2.3 nM) to human A3 adenosine receptor.
V5091 Regadenoson (CVT-3146) 313348-27-5 Regadenoson (CVT3146), a novel and potent A2A adenosine receptor agonist, is a coronary vasodilator that is commonly used in pharmacologic stress testing.
V81281 Regadenoson-d3 (CVT-3146-d3) Regadenoson-d3 is the deuterium labelled form of Regadenoson.
V0351 Reversine 656820-32-5 Reversine is a cell-permeable, selective and ATP-competitive inhibitor of human A3 adenosine receptor and a pan-aurora A/B/C kinase inhibitor as well with potential anticancer activity.
V2917 SCH-58261 160098-96-4 SCH-58261 (SCH58261; SCH 58261) is a novel, potent, selective and competitive antagonist of the adenosine A2A receptor with immunomodulatory and neuroprotective effects.
V75272 SDZ-WAG994 (WAG-994; N6-Cyclohexy-2'-0-methyladenosine) 130714-47-5 SDZ-WAG994 (WAG-994) is a stable, long-acting, selective, orally bioactive A1-adenosine receptor agonist/activator with a KD of 23 nM.
V15215 SR 59230A HCl 1135278-41-9 SR 59230A HCl is a potent, brain penetrant and selective β3 adrenoceptor antagonist with IC50 values of 40, 408 and 648 nM for β3, β1 and β2 receptors respectively.
Contact Us Back to top